News

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...
Underthe shadow of mixed global cues and the impending US tariff deadline; renewed selling from FIIs and profit booking at ...
The Indian market is expected to remain stable on Monday, influenced by global market trends. Nifty futures showed a slight ...
Karnataka CM Siddaramaiah and Biocon chief Kiran Mazumdar-Shaw have been up in arms against each other over the heated debate ...
The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...
Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...
Biocon Ltd's arm, Biocon Biologics Ltd, has received European Commission authorisation for its Vevzuo and Evfraxy biosimilars ...
Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd has announced that the European Commission (EC) has ...
Evfraxy is authorised for the treatment of osteoporosis in men with prostate cancer as increased risk of fractures or ...
Biocon Biologics receives European Commission approval for Vevzuo and Evfraxy, biosimilars of Denosumab, used to treat ...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that ...